SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shawn Murphy who wrote (2098)1/17/1997 7:13:00 PM
From: s martin   of 2281
 
I think #8 would raise the most money but I would guess that #1 will be the approach taken, trouble with this one is whose going to buy it when they see all this? Well, by having a few 2000 to 1 reverse splits, he can get the price back down to .00001 and more people can get in at the 1987 prices, those were the good old days remember? Why you could get nice new car for $20,000 or pay $910.62 and get 91,627,000 shares of ADVR.

Interesting, per the Coca Cola issue...their favorite theme which doesnt answer the question of reticulose at all...but its the best they can do to deflect the question.

To: Joe Scotti (822 )
From: Mary Catherine Koroloff
Aug 26 1996 2:07AM EST
Reply #827 of 2036

"TO ALL:

TAKE YOU'R NEGATIVE BULLSHIT AND GO SOMEWHERE ELSE!!!!"

"To all and Joe Mazzeo:

I take your comments a bit further. I would not be at all surprised that some of the people bashing ADVR are MM's (by the way I've seen them lurking on ther threads) hoping to generate some sells for inventory which will not exist next week!"

Joe(s):

Conversely, how are we to know that the rah-rah-rah-ers aren't MM's trying to run this stock up? I must say that I find the attitude of both of you Joes very offensive. It seems that you can't stand to hear any opinions about this stock that are at variance with your unhesitating promotion of it. Never fall in love with ANY stock, friends.

I respect absolutely your right to think that this company is going to go through the roof, and your right to post messages to that effect -- heck, it's your money. I just hope that you will extend the same courtesy to those of us who might have points of view that differ from yours.

Since my last (and first) posting, I have read the S1, talked to my broker,and must admit that I find myself asking the same questions as Terrance. The patent thing is NOT a dead horse. If this drug is as wonderful as all these posts seem to indicate, the big drug companies will have absolutely no difficulty in finding a way to reproduce it.
To say that Coca Cola does not have a patent and is thus analagous to the situtation with Reticulose demonstrates flawed logic. Coca Cola is not a drug.The analogy that fits more closely to the situation as it stands is aspirin. And how many companies do you know that manufacture that particular wonder drug? Tons. The bottom line is this. The "recipe" for Reticulose is in the public domain now. It was not patented in the '30s, and the window of opportunity for patenting it has passed. I personally don't understand what the three sole employees of ADVR hope to accomplish by spending boku bux on doing research trials on this drug. If they do find that it's effective do begin manufacturing and producing it, there is nothing stopping the big drug companies from going back to the public domain for the 30s "recipe" for Reticulose and marketing it themselves.

I'm sure that the three men who make up ADVR not "dummies." But just because they're smart doesn't mean I'm going to throw up my faculties of critical reasoning and jump on a bandwagon about which I have serious questions to which I have had no satisfactory answer.

BTW -- I am not short or long on this stock, and in no way involved with anything except the search for the truth. Really, I hope that Reticulose DOES do everything that it is touted as being able to do, and I hope that it helps people. I salute ADVR for breaking the ground necessary to bring this drug to the people who need it. That, however, is neither here nor there when discussing the potentials of the company ADVR. My questions, like Terrance's, come from concerns about the viability of the company's position as an entity that can actually take the tiger by the tail and maintain the kind of exclusive rights to manufacture and produce this drug that they will need to have to make the millions & billions of dollars that will be made if this drug proves effective.

Mary Catherine Koroloff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext